×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PLSE – pulse biosciences, inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PLSE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
06:32 am
plse
Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Low
Report
Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
11/13
12:08 am
plse
Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
10/31
02:31 pm
plse
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association [Yahoo! Finance]
Medium
Report
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association [Yahoo! Finance]
10/31
02:25 pm
plse
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association
Medium
Report
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association
10/30
04:05 pm
plse
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results
Low
Report
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results
10/30
04:02 pm
plse
Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology
Low
Report
Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology
10/21
08:00 am
plse
Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024
Medium
Report
Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024
9/20
11:31 pm
plse
Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
10/31
03:02 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Oct 31
Medium
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Oct 31
10/30
04:08 pm
plse
Form 10-Q PULSE BIOSCIENCES, INC. For: Sep 30
Low
Report
Form 10-Q PULSE BIOSCIENCES, INC. For: Sep 30
10/30
04:07 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Oct 30
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Oct 30
9/30
07:39 pm
plse
Form 4 PULSE BIOSCIENCES, INC. For: Sep 24 Filed by: Levinson Mitchell E.
Medium
Report
Form 4 PULSE BIOSCIENCES, INC. For: Sep 24 Filed by: Levinson Mitchell E.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results
33.7%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
TOP News Decliners
2/13
Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in Dermatology
-29.8%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: